Irinotecan Hydrochloide Injection
Product Images NDC 68083-381

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Irinotecan Hydrochloide (NDC 68083-381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irinotecan Spl Carton 2 mL

This text is a description of a drug called "Irinotecan Hydrochloride Injection, USP". It is used for intravenous use only and has to be diluted before use. It contains 40 mg/2 mL of irinotecan. The text provides storage instructions, dosage and use information, and a warning about its cytotoxicity. There are also manufacturing details and codes provided.*

FDA Label Image

Irinotecan Spl Carton 5 mL

This text describes a medication called Irinotecan Hydrochloride which is meant for intravenous use only. It is a cytotoxic agent and comes in a 5mL single dose vial with a strength of 100 mg/5ml. The contents should be diluted before use and caution must be taken while handling. The package code is APIORUGST32011 and it has been manufactured by Prama L in T Visairapaan. It is NDCB08338201 and is available only with a prescription.*

FDA Label Image

Irinotecan Spl Container 2 mL

This is a description of a pharmaceutical product labeled with the National Drug Code 68083-381-01 for Rx Only use. The product is an Injection of Irinotecan Hydrochloride, which is a cytotoxic agent used for intravenous use only. The Injection comes in a 2mL single-dose vial containing 40 mg/2 mL of Irinotecan Hydrochloride, which must be diluted before use. The text also provides cautionary information regarding the toxicity of the drug.*

FDA Label Image

Irinotecan Spl Container 5 mL

This is a label for a medication called Irinotecan Hydrochloride Injection. The medication is a cytotoxic agent that must be diluted before being administered intravenously. It comes in a single dose vial of 5mL with a strength of 100mg/5 (20mg/mL). The label also includes some additional characters and numbers of unclear meaning.*

FDA Label Image

Irinotecan Spl Figure 1

FDA Label Image

Irinotecan Spl Figure 2

FDA Label Image

Irinotecan-spl-figure-3 (Irinotecan Spl Figure 3)

FDA Label Image

Irinotecan-spl-figure-4 (Irinotecan Spl Figure 4)

This appears to be a medical report with limited information. The text mentions "Probability" and "Innotecan 5-FU" which may indicate a treatment plan for a medical condition. The numbers "N 127 129" and "Median follow-up 15 mo" suggest that the report is based on a study or clinical trial involving 127 to 129 participants, with a median follow-up period of 15 months. The final line "Median (mo)" may indicate that the study has a median time point for certain measurements, but without further context, it is difficult to determine the exact meaning.*

FDA Label Image

Irinotecan-spl-structure (Irinotecan Spl Structure)

I'm sorry, but "Irinotecan Hydrochioride" is not enough information to generate a useful description. It seems to be a misspelling of "Irinotecan Hydrochloride," which is a chemotherapy medication used to treat certain types of cancer. However, I cannot provide more information without additional context or text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.